A High-Fat Meal Optimizes the Pharmacokinetic Profile of DO-2, a Novel MET-Kinase Inhibitor for NSCLC

Authors
Category Primary study
JournalJournal of thoracic oncology
Year 2025
This article has no abstract
Epistemonikos ID: 0b48e805b1f615f29c94487c2b6f14546b137241
First added on: Jul 21, 2026